Over-prescription of short-acting β(2)-agonists remains a serious health concern in Kenya: results from the SABINA III study

BACKGROUND: Despite a high asthma burden in Kenya, insights into asthma management practices, including prescription of short-acting β(2)-agonists (SABAs), are lacking. Therefore, this study describes patient demographics, disease characteristics, and asthma treatment patterns in the Kenyan cohort o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakaya, Jeremiah, Mecha, Jared, Beekman, Maarten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329295/
https://www.ncbi.nlm.nih.gov/pubmed/37422638
http://dx.doi.org/10.1186/s12875-023-02030-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329295/
https://www.ncbi.nlm.nih.gov/pubmed/37422638
http://dx.doi.org/10.1186/s12875-023-02030-8

Ejemplares similares